These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15726700)

  • 1. Antibiotic increases risk of sudden death.
    Health News; 2005 Jan; 11(1):2. PubMed ID: 15726700
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral erythromycin and the risk of sudden death.
    Harris JD; de Leon-Casasola OA
    N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15669121
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs and the QT interval - caveat doctor.
    Liu BA; Juurlink DN
    N Engl J Med; 2004 Sep; 351(11):1053-6. PubMed ID: 15356302
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral erythromycin and the risk of sudden death.
    Kaplan EL
    N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15659735
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral erythromycin and the risk of sudden death.
    Winston AP
    N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15669120
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral erythromycin and the risk of sudden death.
    Schoenholtz JC
    N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15669122
    [No Abstract]   [Full Text] [Related]  

  • 7. Macrolides use and the risk of sudden cardiac death.
    Li X; Wang M; Liu G; Zhou L; Wang Z; Li C
    Expert Rev Anti Infect Ther; 2016 Jun; 14(6):535-7. PubMed ID: 27086751
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral erythromycin and the risk of sudden death.
    Amory JK; Amory DW
    N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15669119
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythromycin and ketoconazole (Nizoral) associated with terfenadine (Seldane)-induced ventricular arrhythmias.
    Wynn RL
    Gen Dent; 1993; 41(1):27-9. PubMed ID: 7489857
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-induced q-T prolongation.
    Kao LW; Furbee RB
    Med Clin North Am; 2005 Nov; 89(6):1125-44, x. PubMed ID: 16227057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Torsades de pointes caused by the association of terfenadine and erythromycin].
    Gully C; Riem R
    Ann Med Interne (Paris); 1994; 145(4):257-8. PubMed ID: 8092653
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of torsades de pointes from oral erythromycin with concomitant carbimazole (methimazole) administration.
    Koh TW
    Pacing Clin Electrophysiol; 2001 Oct; 24(10):1575-6. PubMed ID: 11707056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic agents associated with QT interval prolongation.
    Olsen KM
    J Fam Pract; 2005 Jun; Suppl():S8-S14. PubMed ID: 15938993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining erythromycin with other drugs may lead to sudden death.
    Mayo Clin Womens Healthsource; 2005 Mar; 9(3):3. PubMed ID: 15689849
    [No Abstract]   [Full Text] [Related]  

  • 15. Azithromycin-induced torsade de pointes.
    Huang BH; Wu CH; Hsia CP; Yin Chen C
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1579-82. PubMed ID: 18070319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral erythromycin and the risk of sudden death from cardiac causes.
    Ray WA; Murray KT; Meredith S; Narasimhulu SS; Hall K; Stein CM
    N Engl J Med; 2004 Sep; 351(11):1089-96. PubMed ID: 15356306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proarrhythmic effects of anti-arrhythmic agents.
    Bayés de Luna A; Guindo J; Elosua R; Viñolas X; Bayés-Genis A; Sobral J; Sztajzel J; Boveda S
    Postgrad Med J; 1994; 70 Suppl 1():S84-8. PubMed ID: 7971655
    [No Abstract]   [Full Text] [Related]  

  • 18. What has the patient been taking?
    Pasco J
    Aust Fam Physician; 1998 Jun; 27(6):517. PubMed ID: 9648320
    [No Abstract]   [Full Text] [Related]  

  • 19. Domperidone and sudden death. Cardiac rhythm disorders: QT interval prolongation.
    Prescrire Int; 2008 Apr; 17(94):67. PubMed ID: 18540123
    [No Abstract]   [Full Text] [Related]  

  • 20. QT prolongation and torsades de pointes associated with concurrent use of cisapride and erythromycin.
    Kyrmizakis DE; Chimona TS; Kanoupakis EM; Papadakis CE; Velegrakis GA; Helidonis ES
    Am J Otolaryngol; 2002; 23(5):303-7. PubMed ID: 12239699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.